hepatitis viruses


Summary: Any of the viruses that cause inflammation of the liver. They include both DNA and RNA viruses as well viruses from humans and animals.

Top Publications

  1. Alexopoulou A, Dourakis S. Genetic heterogeneity of hepatitis viruses and its clinical significance. Curr Drug Targets Inflamm Allergy. 2005;4:47-55 pubmed
    ..Consequently the duration of treatment has been tailored according to HCV genotype...
  2. Makuwa M, Souquiere S, Telfer P, Bourry O, Rouquet P, Kazanji M, et al. Hepatitis viruses in non-human primates. J Med Primatol. 2006;35:384-7 pubmed
    ..In order to investigate the prevalence of the blood-born hepatitis viruses in apes and monkeys living in the same area, we performed an epidemiological survey of HBV, HCV and HDV in ..
  3. Rohrig S, Grob P. [Infection with hepatitis viruses HAV, HBV and HCV as well as with AIDS virus HIV in drug addicts of the Zurich street scene--a prevalence study]. Schweiz Med Wochenschr. 1990;120:621-9 pubmed
    382 i.v. drug abusers were tested for a past or ongoing infection with the hepatitis viruses A (HAV), B (HBV), the newly discovered C (HCV) and with the Aids virus HIV. The cohort studied was representative for i.v...
  4. Safadi R, Or R, Ilan Y, Naparstek E, Nagler A, Klein A, et al. Lack of known hepatitis virus in hepatitis-associated aplastic anemia and outcome after bone marrow transplantation. Bone Marrow Transplant. 2001;27:183-90 pubmed
    ..HGV, TTV and parvovirus B19 sequences were not detected in any of the HAAA cases. The survival rate after BMT with stem cells from an HLA-matched sibling is similar to that for patients with non-hepatitis-associated aplastic anemia...
  5. Fracanzani A, Fargion S, Stazi M, Valenti L, Amoroso P, Cariani E, et al. Association between heterozygosity for HFE gene mutations and hepatitis viruses in hepatocellular carcinoma. Blood Cells Mol Dis. 2005;35:27-32 pubmed
    ..However, the interaction between HFE gene mutations and hepatitis viruses for HCC development has not been systematically searched for...
  6. Pujol F, Devesa M. Genotypic variability of hepatitis viruses associated with chronic infection and the development of hepatocellular carcinoma. J Clin Gastroenterol. 2005;39:611-8 pubmed
    At least five hepatitis viruses are known to date. Infection by enterically transmitted viruses (HAV and HEV) is generally benign compared with the disease caused by parenterally transmitted viruses (HBV, HCV, and HDV)...
  7. El Esnawy N, Al Herrawy A. Seroprevalence of certain hepatitis viruses among Egyptian workers infected with schistosomiasis. J Egypt Public Health Assoc. 2000;75:357-66 pubmed
    ..Out of the four (WWTP), the workers at Helwan exhibited the highest infection rate...
  8. Xu R, Gan X, Fang Y, Zheng S, Dong Q. A simple, rapid, and sensitive integrated protein microarray for simultaneous detection of multiple antigens and antibodies of five human hepatitis viruses (HBV, HCV, HDV, HEV, and HGV). Anal Biochem. 2007;362:69-75 pubmed
    ..HBsAg, HBeAg) and seven viral antibodies (HBsAb, HBcAb, HBeAb, HCVAb, HDVAb, HEVAb, HGVAb) of human hepatitis viruses within 20 min...
  9. Guan Y, He Q, Wang M, Li P. Nuclear factor kappa B and hepatitis viruses. Expert Opin Ther Targets. 2008;12:265-80 pubmed publisher
    ..Nuclear factor kappa B (NF-kappaB) is critical for immune and inflammatory responses. During its lifetime the cell demands specific and highly regulated control of NF-kappaB activity...

More Information

Publications138 found, 100 shown here

  1. Park S, Rehermann B. Immune responses to HCV and other hepatitis viruses. Immunity. 2014;40:13-24 pubmed publisher
    Five human hepatitis viruses cause most of the acute and chronic liver disease worldwide...
  2. Turner P, Sylla A, Diallo M, Castegnaro J, Hall A, Wild C. The role of aflatoxins and hepatitis viruses in the etiopathogenesis of hepatocellular carcinoma: A basis for primary prevention in Guinea-Conakry, West Africa. J Gastroenterol Hepatol. 2002;17 Suppl:S441-8 pubmed
    ..This study will evaluate the effectiveness of improving the post-harvest processing and storage of the groundnut crop, a major source of aflatoxins, using aflatoxin-albumin adducts as the outcome measurement...
  3. Youssef A, Yano Y, Utsumi T, abd El alah E, abd El Hameed A, Serwah A, et al. Molecular epidemiological study of hepatitis viruses in Ismailia, Egypt. Intervirology. 2009;52:123-31 pubmed publisher
    ..Our project aimed to clarify the carrier rate of various hepatitis viruses in the northeastern province of Ismailia...
  4. Nerurkar V, Woodward C, Nguyen H, DeWolfe Miller F, Tashima L, Zalles Ganley A, et al. Lack of association between acquisition of TT virus and risk behavior for HIV and HCV infection in Vietnam. Int J Infect Dis. 1999;3:181-5 pubmed
  5. Hovi T, Järvinen A, Pyhälä R, Ristola M, Salminen M. [Viruses and antiviral drug resistance]. Duodecim. 2002;118:911-8 pubmed
  6. Germain M, Gélinas S, Delage G. Estimates of risk of window-period transmission of blood-borne viral diseases in Quebec. CMAJ. 2004;170:1077-8 pubmed
  7. Cornberg M, Schlevogt B, Rademacher J, Schwarz A, Sandherr M, Maschmeyer G. [Specific infections in organ transplantation]. Internist (Berl). 2016;57:38-48 pubmed publisher
    ..The focus of this section is on three common pathogens: cytomegalovirus, polyomavirus BK and hepatitis viruses.The final section deals with Aspergillus infections following transplantation of various organs...
  8. Novakova L, Pavlík J, Chrenková L, Martinec O, Cerveny L. Current antiviral drugs and their analysis in biological materials - Part II: Antivirals against hepatitis and HIV viruses. J Pharm Biomed Anal. 2018;147:378-399 pubmed publisher
    ..viruses and antivirals against respiratory viruses were addressed, this part concerns antivirals against hepatitis viruses (B and C) and human immunodeficiency virus (HIV)...
  9. Simmonds P. Transfusion virology: progress and challenges. Blood Rev. 1998;12:171-7 pubmed
    ..Establishing a framework for PCR-based screening would also enable the testing for others such as hepatitis A virus, parvovirus B19 and GBV-C/HGV for which serological detection methods cannot be or have not been developed...
  10. Bergeron L, Perreault J. Target-dependent on/off switch increases ribozyme fidelity. Nucleic Acids Res. 2005;33:1240-8 pubmed
    ..This new approach provides a highly specific and improved tool with significant potential for application in the fields of both functional genomics and gene therapy. ..
  11. Schröder M. Human DEAD-box protein 3 has multiple functions in gene regulation and cell cycle control and is a prime target for viral manipulation. Biochem Pharmacol. 2010;79:297-306 pubmed publisher
    ..Understanding the viral strategies for manipulating or co-opting DDX3 in functional and molecular detail can provide valuable insights for the development of strategies to therapeutically target DDX3. ..
  12. Reda A, Fisseha S, Mengistie B, Vandeweerd J. Standard precautions: occupational exposure and behavior of health care workers in Ethiopia. PLoS ONE. 2010;5:e14420 pubmed publisher
    ..for health care workers, and presents a major risk for the transmission of infections such as HIV and hepatitis viruses. The objective of this study was to investigate occupational exposures and behavior of health care workers (..
  13. Li D, Yang W, Zhang J, Yang J, Guan R, Yang M. Transcription Factor and lncRNA Regulatory Networks Identify Key Elements in Lung Adenocarcinoma. Genes (Basel). 2018;9: pubmed publisher
    ..Specifically, our results suggest that hepatitis viruses may contribute to lung carcinogenesis, highlighting the need for further investigations into the roles that ..
  14. de Almeida O, Scully C, Jorges J. Hepatitis B vaccination and infection control in Brazilian dental practice, 1990. Community Dent Oral Epidemiol. 1991;19:225-7 pubmed
    ..These results indicate the urgent need for a campaign to improve infection control procedures in Brazilian dental practice. ..
  15. Tameda Y. [Hepatitis viruses]. Rinsho Byori. 1996;44:838-46 pubmed
    The existence of five kinds of hepatitis viruses such as hepatitis A, B, C, D and E has been convinced since 1967 when Blumberg discovered hepatitis B virus...
  16. McCreaddie M. The hepatitis viruses. Rationales for treatment, occupation health issues and current guidelines for best practice. Nurs Times. 2001;97:39-42 pubmed
    Nurses are likely to come across any one, or all, of the hepatitis viruses A, B, C, D, E, (F) and G at some point in their career...
  17. Stock P, Roland M. Evolving clinical strategies for transplantation in the HIV-positive recipient. Transplantation. 2007;84:563-71 pubmed
    ..This overview will describe the evolving clinical strategies that have resulted in good outcomes after solid organ transplantation in the HIV-positive recipient. ..
  18. Schaefer S. [Sexually transmissible hepatitis viruses]. Hautarzt. 2009;60:456-64 pubmed publisher
    The transmission of hepatitis viruses as a result of sexual activity is a common problem in medical practice. A system of stages is proposed to diagnose viral hepatitis...
  19. He J, Yu G, Li Z, Liang H. Influence of interleukin-28B polymorphism on progression to hepatitis virus-induced hepatocellular carcinoma. Tumour Biol. 2014;35:8757-63 pubmed publisher
    ..The combined data suggest that IL-28B rs12979860 T/C polymorphism seems to augment the risk of developing HCC, especially in Caucasians. ..
  20. Jabłkowski M, Kuydowicz J, Strzelczyk J, Białkowska J. Prevalence of markers of hepatotropic viruses A, B, C and the efficacy of vaccination against hepatitis A and hepatitis B among medical students. Med Sci Monit. 2002;8:CR762-6 pubmed
    ..The presence of anti-HBs 4 years after vaccination was detected in 97.3% of the students, and anti-HAV 1 month after the complete course of vaccination in 100% of cases. ..
  21. Gardner S, Kuczmarski T, Vitalis E, Slezak T. Limitations of TaqMan PCR for detecting divergent viral pathogens illustrated by hepatitis A, B, C, and E viruses and human immunodeficiency virus. J Clin Microbiol. 2003;41:2417-27 pubmed
    ..that are nevertheless of public health concern: human immunodeficiency virus (HIV) and four species of hepatitis viruses. Fluorogenic probe-based PCR assays (TaqMan; Perkin-Elmer Corp., Applied Biosystems, Foster City, Calif...
  22. Cuadrado A, Crespo J. Hypertransaminasemia in patients with negative viral markers. Rev Esp Enferm Dig. 2004;96:484-92, 492-500 pubmed
  23. Kaneko M, Arakawa Y, Moriyama M. [Detection of SEN-V]. Nihon Rinsho. 2004;62 Suppl 8:598-601 pubmed
  24. Modi A, Nazario H, Trotter J, Gautam M, Weinstein J, Mantry P, et al. Safety and efficacy of simeprevir plus sofosbuvir with or without ribavirin in patients with decompensated genotype 1 hepatitis C cirrhosis. Liver Transpl. 2016;22:281-6 pubmed publisher
    ..In conclusion, SOF plus SIM was very well tolerated in patients with advanced Child B/C decompensated cirrhosis. Overall, 74% of patients achieved SVR12; 100% of patients with genotype 1b decompensated cirrhosis achieved SVR12. ..
  25. Makiala Mandanda S, Le Gal F, Ngwaka Matsung N, Ahuka Mundeke S, Onanga R, Bivigou Mboumba B, et al. High Prevalence and Diversity of Hepatitis Viruses in Suspected Cases of Yellow Fever in the Democratic Republic of Congo. J Clin Microbiol. 2017;55:1299-1312 pubmed publisher
    ..Genotypes A, E, and D of HBV and genotype 1 of HDV were detected. These high hepatitis prevalence rates highlight the necessity to include screening for hepatitis viruses in the yellow fever surveillance program in the DRC.
  26. Yoshida E, Buczkowski A, Giulivi A, Zou S, Forrester L. A cross-sectional study of SEN virus in liver transplant recipients. Liver Transpl. 2001;7:521-5 pubmed
    ..There is a suggestion that SEN V may be associated with HCV recurrence, but we did not detect biochemical differences attributable to SEN V. ..
  27. Olal S, Akere A, Otegbayo J, Odaibo G, Olaleye D, Afolabi N, et al. Are patients with primary hepatocellular carcinoma infectious of hepatitis B, C and D viruses?. Afr J Med Med Sci. 2012;41 Suppl:187-91 pubmed
    ..Hence, safe medical care should be practised for all patients with PHCC while relatives should be screened for these viruses. ..
  28. Asham E, Kaseb A, Ghobrial R. Management of hepatocellular carcinoma. Surg Clin North Am. 2013;93:1423-50 pubmed publisher
    ..Because of the heterogeneity of the patients and the disease, many questions are waiting for answers through well-designed, adequately powered, and bias-free multicenter, controlled, randomized trials. ..
  29. Reynolds N, Dearnley M, Hinton T. Polymers in the Delivery of siRNA for the Treatment of Virus Infections. Top Curr Chem (Cham). 2017;375:38 pubmed publisher
    ..Predominant viruses include human immunodeficiency virus, hepatitis viruses, and gastrointestinal and respiratory viruses...
  30. Unsal V, Belge Kurutas E. Experimental Hepatic Carcinogenesis: Oxidative Stress and Natural Antioxidants. Open Access Maced J Med Sci. 2017;5:686-691 pubmed publisher
    ..world, and it is influenced by agents such as DEN, 2-AAF, phenobarbital, alcohol, aflatoxin B1 metabolite or hepatitis viruses (B and C)...
  31. Lizee G, Aerts J, Gonzales M, Chinnasamy N, Morgan R, Topalian S. Real-time quantitative reverse transcriptase-polymerase chain reaction as a method for determining lentiviral vector titers and measuring transgene expression. Hum Gene Ther. 2003;14:497-507 pubmed
  32. Eksteen B. Infections and the liver. Dig Dis. 2011;29:184-90 pubmed publisher
    ..Increased appreciation of the interaction between host factors and the viral life cycles is likely to significantly alter the way we target these infections in the future. ..
  33. Yang Y, Deng L, Li X, Shi Z, Chen D, Chen X, et al. Evaluation of the prognosis of fulminant viral hepatitis in late pregnancy by the MELD scoring system. Eur J Clin Microbiol Infect Dis. 2012;31:2673-8 pubmed
    ..05). The concordance (c-statistic) values were all greater than 0.8. The MELD scoring system shows excellent short-term predictive value for the prognosis of FVHILP. ..
  34. Lavender K, Gibbert K, Peterson K, Van Dis E, Francois S, Woods T, et al. Interferon Alpha Subtype-Specific Suppression of HIV-1 Infection In Vivo. J Virol. 2016;90:6001-6013 pubmed publisher
    ..The naturally occurring antiviral protein IFN-?2 is used to treat hepatitis viruses but has proven rather ineffective against HIV in comparison to triple therapy with the antiretroviral (ARV) ..
  35. Arora D, Sehgal R, Gupta N, Yadav A, Mishra N, Siwach S. Prevalence of parenterally transmitted hepatitis viruses in clinically diagnosed cases of hepatitis. Indian J Med Microbiol. 2005;23:44-7 pubmed
    ..28%) cases. The prevalence of anti-HCV was 3 (4.28%) in 70 cases. Thus early screening of clinically diagnosed cases of viral hepatitis is essential for establishing diagnosis and treatment to prevent long term sequelae. ..
  36. Guenet J. Assessing the genetic component of the susceptibility of mice to viral infections. Brief Funct Genomic Proteomic. 2005;4:225-40 pubmed
    ..These genes are probably numerous, however, and many of them presumably interact with each other and/or have additive effects. This might slow down progress in our understanding of the innate mechanism of defence. ..
  37. Rafiq S, Rashid H, Haworth E, Booy R. Hazards of hepatitis at the Hajj. Travel Med Infect Dis. 2009;7:239-46 pubmed publisher
    ..Improved health education to increase awareness about the risk of these diseases and appropriate immunisations, particularly hepatitis A and B vaccines, could play an important role. ..
  38. Banks L, Pim D, Thomas M. Human tumour viruses and the deregulation of cell polarity in cancer. Nat Rev Cancer. 2012;12:877-86 pubmed publisher
    ..However, a body of data from human tumour viruses is now providing compelling evidence of a central role for the perturbation of cell polarity in the development of cancer. ..
  39. Fantin Y, Neverov A, Favorov A, Alvarez Figueroa M, Braslavskaya S, Gordukova M, et al. Base-calling algorithm with vocabulary (BCV) method for analyzing population sequencing chromatograms. PLoS ONE. 2013;8:e54835 pubmed publisher
  40. Irshad M, Ansari M, Irshad K, Lingaiah R. Novel single-step multiplex real-time polymerase chain reaction assay for simultaneous quantification of hepatitis virus A, B, C, and E in serum. J Gastroenterol Hepatol. 2013;28:1869-76 pubmed publisher
    ..Present multiplex real-time PCR is the first report on single-step nucleic acid detection of HAV, HBV, HCV, and HEV in sera samples. It is an alternate diagnostic assay for common use in laboratories analyzing viral hepatitis cases. ..
  41. Koziel M. Immunology of viral hepatitis. Am J Med. 1996;100:98-109 pubmed
  42. Robertson B. Viral hepatitis and primates: historical and molecular analysis of human and nonhuman primate hepatitis A, B, and the GB-related viruses. J Viral Hepat. 2001;8:233-42 pubmed
    The hepatitis viruses have long been assumed to be highly host-specific, with infection of other nonhuman primates occurring due to inoculation with, or exposure to, human viruses...
  43. Konomi N, Lebwohl E, Zhang D. Comparison of DNA and RNA extraction methods for mummified tissues. Mol Cell Probes. 2002;16:445-51 pubmed
    ..We further tested hepatitis viruses including hepatitis B virus, hepatitis C virus, hepatitis G virus, and TT virus DNA, and fail to detect ..
  44. Rinaldo C, Piazza P. Virus infection of dendritic cells: portal for host invasion and host defense. Trends Microbiol. 2004;12:337-45 pubmed
    ..Engineering of DCs with various forms of viral immunogens and co-treatment with cytokines and chemokines is being used as an immunotherapy for HIV-1 and other viral infections. ..
  45. Cohen J, Miller R, Rosenblum B, Denniston K, Gerin J, Purcell R. Sequence comparison of woodchuck hepatitis virus replicative forms shows conservation of the genome. Virology. 1988;162:12-20 pubmed
    ..Thus, the nucleotide sequence of two different replicative forms of WHV DNA, separated by two in vivo passages, were virtually identical. ..
  46. Dejucq N, Jegou B. Viruses in the mammalian male genital tract and their effects on the reproductive system. Microbiol Mol Biol Rev. 2001;65:208-31 ; first and second pages, table of contents pubmed
    ..Progress in all these domains is essential for the development of new treatment strategies to eradicate viruses and to correct the virus-induced dysfunction of the endocrine system. ..
  47. Wolk D, Jones M, Rosenblatt J. Laboratory diagnosis of viral hepatitis. Infect Dis Clin North Am. 2001;15:1109-26 pubmed
    ..Both qualitative and quantitative molecular assays are available, and their efficient use requires familiarity with the sensitivity and dynamic ranges of each method. ..
  48. Kershenobich D. [Molecular biology in gastroenterology]. Rev Invest Clin. 2003;55:181-5 pubmed
  49. Sehgal R. SEN virus infection--a new hepatitis virus: a review. Indian J Pathol Microbiol. 2003;46:253-5 pubmed
    ..The present review summarizes the present available data on this new agent of hepatitis. ..
  50. Tserenpuntsag B, Tserenpuntsag B, Kuydowicz J, Jabłonowska E. [Primary hepatotropic viral infections in Mongolia]. Przegl Epidemiol. 2008;62:425-32 pubmed
  51. Echevarria J, Avellón A. [Utility of molecular biology in the microbiological diagnosis of viral hepatitides]. Enferm Infecc Microbiol Clin. 2008;26 Suppl 9:66-74 pubmed
  52. Weston S, Martin P. Serological and molecular testing in viral hepatitis: an update. Can J Gastroenterol. 2001;15:177-84 pubmed
    ..Increasingly, molecular virology is also being used to evaluate patients with chronic hepatitis C, with genotype and viral load testing to plan therapy. ..
  53. Okamoto H, Mayumi M. [Hepatitis viruses]. Nihon Naika Gakkai Zasshi. 2002;91:556-60 pubmed
  54. Tabor E, Epstein J. NAT screening of blood and plasma donations: evolution of technology and regulatory policy. Transfusion. 2002;42:1230-7 pubmed
  55. Narayanan Menon K. Non-A to E hepatitis. Curr Opin Infect Dis. 2002;15:529-34 pubmed
    ..The discovery of these viruses, however, paves the way for further research into novel viral agents that infect humans, other among hosts. ..
  56. Harris K, Dighe A. Laboratory testing for viral hepatitis. Am J Clin Pathol. 2002;118 Suppl:S18-25 pubmed
    Worldwide, infection with hepatitis viruses remains a major clinical and public heath concern...
  57. Aguilera Guirao A, Romero Yuste S, Regueiro B. [Epidemiology and clinical manifestations of viral hepatitis]. Enferm Infecc Microbiol Clin. 2006;24:264-76 pubmed
    Viral hepatitis is an infectious disease affecting the liver. At this time, five different human hepatitis viruses are recognized and characterized in detail: Hepatitis A virus (HAV), hepatitis B virus (HBV), hepatitis C virus (HCV), ..
  58. Mihigo R, Nshimirimana D, Hall A, Kew M, Wiersma S, Clements C. Control of viral hepatitis infection in Africa: are we dreaming?. Vaccine. 2013;31:341-6 pubmed publisher
    ..Such a project will inevitably involve multiple strategies that will vary somewhat according to the epidemiology of the diseases and the location. ..
  59. Gori A, Gheorgita S, Spinu C, Pinzaru I, Halacu A, Sajen O, et al. Hepatitis B, C and D virus genotypes detected in HBsAg- or anti-HCV-positive people from the Republic of Moldova. Arch Virol. 2018;163:431-438 pubmed publisher
    ..5%). Thus, genotypes prevalent in Europe were detected for all three hepatitis viruses. For both HBV and HCV, one genotype was dominant, while occasional other variants seem to be restricted to ..
  60. Zheng W, Zheng H. [Application of real-time homogeneous PCR in the research for liver diseases]. Zhonghua Gan Zang Bing Za Zhi. 2003;11:254-6 pubmed
  61. Gandolfo G, Ferri G, Conti L, Antenucci A, Marrone R, Frasca A, et al. [Prevalence of infections by hepatitis A, B, C and E viruses in two different socioeconomic groups of children from Santa Cruz, Bolivia]. Med Clin (Barc). 2003;120:725-7 pubmed
    ..Spreading of viral hepatitis can be controlled upon improving hygienic conditions and customs. Moreover, a vaccination plan against hepatitis A and B virus is necessary for the population living in endemic areas. ..
  62. Ye Q, Tong J, Shi M, Bao G. [A seroepidemiological study of hepatitis viruses among the patients with different types of liver disease in Qinhuangdao]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 1997;11:37-40 pubmed
    ..93 times higher than that in AH and CH. It seems that the super infection of HBV and HCV was the main factor for worsened liver symptoms and for developing LC and HCC. ..
  63. Sulkowski M. The HIV-coinfected patient: managing viral hepatitis. J Acquir Immune Defic Syndr. 2007;45 Suppl 2:S36-7 pubmed
  64. Ishiguro S, Inoue M, Tanaka Y, Mizokami M, Iwasaki M, Tsugane S. Serum aminotransferase level and the risk of hepatocellular carcinoma: a population-based cohort study in Japan. Eur J Cancer Prev. 2009;18:26-32 pubmed publisher
    ..This finding indicates that ALT level is a good independent determinant of the need for intervention. Clinical application of these findings may help decrease HCC-associated mortality in hepatitis virus-endemic regions. ..
  65. Karnchanasorn R, Ou H, Lin J, Chuang L, Chiu K. Viral Hepatitis and Diabetes: Clinical Implications of Diabetes Prevention Through Hepatitis Vaccination. Curr Diab Rep. 2016;16:101 pubmed publisher
    ..In this review, we discuss hepatitis viruses A, B, and C and their interaction with diabetes; explore the potential underlying mechanisms and potential ..
  66. Tomono T, Murokawa H, Minegishi K, Yamanaka R, Lizuka H, Miyamoto M, et al. Status of NAT screening for HCV, HIV and HBV: experience in Japan. Dev Biol (Basel). 2002;108:29-39 pubmed
    ..During the 50-mini-pool NAT screening of serologically negative donations (February 1, 2001-April 30, 2001), we were able to screen out 112 HBV-positive, 25 HCV-positive, and 4 HIV-1 positive units from blood and blood components. ..
  67. Yeh C, Hsu C, Chang M, Tsao M. Impact of the novel hepatotropic viruslike agent NV-F during chronic hepatitis C virus infection. J Infect Dis. 2008;198:1742-8 pubmed publisher
    ..In conclusion, coinfection of the NV-F agent in chronic HCV infection is associated with more severe hepatitis activity. ..
  68. Okamoto H, Nishizawa T, Ukita M, Takahashi M, Fukuda M, Iizuka H, et al. The entire nucleotide sequence of a TT virus isolate from the United States (TUS01): comparison with reported isolates and phylogenetic analysis. Virology. 1999;259:437-48 pubmed publisher
    ..Divergent sequences in coding regions would be useful as primers for distinguishing various TTV genotypes...
  69. Irshad M, Peter S. Spectrum of viral hepatitis in thalassemic children receiving multiple blood transfusions. Indian J Gastroenterol. 2002;21:183-4 pubmed
    To investigate the prevalence of infection with hepatitis viruses in children with thalassemia receiving multiple blood transfusions...
  70. Louisirirotchanakul S, Myint K, Srimee B, Kanoksinsombat C, Khamboonruang C, Kunstadter P, et al. The prevalence of viral hepatitis among the Hmong people of northern Thailand. Southeast Asian J Trop Med Public Health. 2002;33:837-44 pubmed
    ..The role of TTV and HGV in producing illness and hepatic disease has yet to be determined in this population. ..
  71. Delgado Enciso I, Rojas Martinez A, Barrera Saldaña H, Ortiz Lopez R. [Viruses: an important cause of human cancer]. Rev Invest Clin. 2004;56:495-506 pubmed
    ..Great efforts are being initiated to decrease incidence of the neoplasms by preventing the initial infection or by prophylactic vaccination. ..
  72. Ait Goughoulte M, Kanda T, Meyer K, Ryerse J, Ray R, Ray R. Hepatitis C virus genotype 1a growth and induction of autophagy. J Virol. 2008;82:2241-9 pubmed
    ..Taken together, our results suggested that HCV genotype 1a (clone H77) can be serially passaged in IHH and that HCV infection induces an autophagic response in hepatocytes. ..
  73. Luo W, Chen Y, Wang M, Chen Y, Zheng Z, Song H, et al. Peptide mimics of a conserved H5N1 avian influenza virus neutralization site. Biochem J. 2009;419:133-9 pubmed publisher
  74. Bosan A, Qureshi H, Bile K, Ahmad I, Hafiz R. A review of hepatitis viral infections in Pakistan. J Pak Med Assoc. 2010;60:1045-58 pubmed
    ..This review was used as the basis for the launch of hepatitis programme, but putting it into a formal review took time and the hepatitis program was initiated. ..
  75. Antonelli G, Turriziani O. Antiviral therapy: old and current issues. Int J Antimicrob Agents. 2012;40:95-102 pubmed publisher
    ..This review aims to discuss some of these issues in the belief that they should be carefully addressed to enhance the management of patients with viral infections. ..
  76. Iriyama M, Kimura H, Nishikawa K, Yoshioka K, Wakita T, Nishimura N, et al. The prevalence of TT virus (TTV) infection and its relationship to hepatitis in children. Med Microbiol Immunol. 1999;188:83-9 pubmed
    ..The larger quantity of TTV-DNA in infants and the high prevalence of TTV in children of all ages suggest that TTV may be transmitted in early childhood. Its relationship to hepatitis is doubtful in children. ..
  77. Liu K, Liao Y, Wang Z, Li S, Wang M, Zeng L, et al. Effects of autoantibodies against beta(1)-adrenoceptor in hepatitis virus myocarditis on action potential and L-type Ca(2+) currents. World J Gastroenterol. 2004;10:1171-5 pubmed
    ..Autoantibodies against beta(1)-adrenoceptor may result in arrhythmias and/or impairment of myocardiums in HVM, which would be mediated by the enhancement of I(Ca-L). ..
  78. Poleshchuk V, Mikhailov M, Zamiatina N. [Primate models of human viral hepatitis]. Vopr Virusol. 2006;51:6-13 pubmed
    ..A comparative analysis of the etiological agents--the causative agents of simian and human hepatitis will give a better insight into the evolution of its viruses. ..
  79. Dwivedi M, Manocha H, Tiwari S, Tripathi G, Dhole T. Coinfection of parvovirus b19 with other hepatitis viruses leading to fulminant hepatitis of unfavorable outcome in children. Pediatr Infect Dis J. 2009;28:649-50 pubmed publisher
    ..Clinical characteristics of 3 pediatric groups with FHF were compared and it was observed that B19 coinfection with other viruses adds to the severity of the disease and increases the probability of a fatal outcome. ..
  80. Kuramoto J, Arai E, Tian Y, Funahashi N, Hiramoto M, Nammo T, et al. Genome-wide DNA methylation analysis during non-alcoholic steatohepatitis-related multistage hepatocarcinogenesis: comparison with hepatitis virus-related carcinogenesis. Carcinogenesis. 2017;38:261-270 pubmed publisher
    ..These data suggested that NASH-specific DNA methylation alterations may participate in NASH-related multistage hepatocarcinogenesis...
  81. Mutimer D. Hepatitis B virus infection: resistance to antiviral agents. J Clin Virol. 2001;21:239-42 pubmed
    ..Preliminary data suggest that adefovir achieves potent inhibition of both species. Studies of drug resistance have followed hot-on-the-heels of the development of potent antiviral therapy for chronic HBV...
  82. Hart C, Beeching N. New pathogens. Curr Opin Infect Dis. 2002;15:497-500 pubmed
  83. Wisnom C, Siegel M. Advances in the diagnosis and management of human viral hepatitis. Dent Clin North Am. 2003;47:431-47 pubmed
    ..By using this information, dental health care workers can be assured that they are practicing "state-of-the-art dentistry" while ensuring the health of their patients, staff, and families...
  84. Jacob J, Mansfield K, You J, Tennant B, Kim Y. Natural iminosugar derivatives of 1-deoxynojirimycin inhibit glycosylation of hepatitis viral envelope proteins. J Microbiol. 2007;45:431-40 pubmed
  85. Lisker Melman M. [Serological markers in viral hepatitis]. Rev Invest Clin. 1990;42 Suppl:3-8 pubmed
  86. Stephenson J. Giving HIV the silent treatment and other strategies examined at conference. JAMA. 2003;289:1494-5 pubmed
  87. Duburcq X, Olivier C, Malingue F, Desmet R, Bouzidi A, Zhou F, et al. Peptide-protein microarrays for the simultaneous detection of pathogen infections. Bioconjug Chem. 2004;15:307-16 pubmed
    ..Peptide-protein microarrays displayed high signal-to-noise ratios, sensitivities, and specificities for the detection of antibodies as revealed by the analysis of a collection of human sera referenced against these five pathogens...
  88. Wachtel M, Zhang Y, Kaye K, Chiriva Internati M, Frezza E. Increased age, male gender, and cirrhosis, but not steatosis or a positive viral serology, negatively impact the life expectancy of patients who undergo liver biopsy. Dig Dis Sci. 2007;52:2276-81 pubmed
    ..15). Steatosis and a positive viral serology did not increase the risk of death. Male gender, increased age, and cirrhosis increased the risk of death; increased steatosis and positive viral serologic studies did not...
  89. Gaze R, Carvalho D, Santoro Lopes G, Tura L. From hepatic diseases and jaundice to viral hepatitis: the configuration of a kaleidoscope. Rev Saude Publica. 2013;47:116-22 pubmed
    ..In other words, it highlights the need to explore singularities in order to be able to develop new proposals for general actions tailored to local specificities...
  90. Smit P, Elliott I, Peeling R, Mabey D, Newton P. An overview of the clinical use of filter paper in the diagnosis of tropical diseases. Am J Trop Med Hyg. 2014;90:195-210 pubmed publisher
    ..DBS have great potential to empower healthcare workers by making laboratory-based diagnostic tests more readily accessible, but additional and more rigorous research is needed...
  91. Linnen J, Wages J, Zhang Keck Z, Fry K, Krawczynski K, Alter H, et al. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science. 1996;271:505-8 pubmed
    ..Persistent viremia was detected for up to 9 years in patients with hepatitis. The virus is transfusion-transmissible. It has a global distribution and is present within the volunteer blood donor population in the United States...
  92. Farci P. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome [Science 1989;244:359-362]. J Hepatol. 2002;36:582-5 pubmed